4//SEC Filing
Carle Vanessa 4
Accession 0001348362-25-000009
CIK 0001348362other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:27 PM ET
Size
12.5 KB
Accession
0001348362-25-000009
Insider Transaction Report
Form 4
Carle Vanessa
Secretary
Transactions
- Award
Stock Options
2025-05-15+15,000→ 75,000 totalExercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (15,000 underlying)
Holdings
- 12,500
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (12,500 underlying) - 17,500
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying) - 27,500
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying) - 40,000
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (12,500 underlying) - 50,000
Stock Options
Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (10,000 underlying) - 60,000
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (10,000 underlying)
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001855763
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 5:27 PM ET
- Size
- 12.5 KB